The physiological role of RIPK3-dependent necroptosis

RIPK3依赖性坏死性凋亡的生理作用

基本信息

  • 批准号:
    9193610
  • 负责人:
  • 金额:
    $ 44.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-01-01 至 2018-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Tumor Necrosis Factor-� (TNF) and Toll-like receptor (TLR) signaling play key roles in coordinating immune responses, by driving the transcriptional activation of pro-inflammatory genes. However, it has long been recognized that they can also trigger apoptotic cell death. More recently, it has been shown that these signals can also induce another form of programmed cell death, called "necroptosis." While the discovery of necroptosis has generated considerable interest, the physiological role of this alternate cell death program remains elusive. In particular, necroptosis is blocked by the pro-apoptotic protease caspase-8, so most studies rely on genetic ablation or chemical inhibition of caspase-8 to trigger necroptosis. This raises a question: when does TNF or TLR-mediated necroptosis occur under physiological conditions? We have shown that caspase-8 must act in concert with its paralog FLIP to block necroptosis, and FLIP is potently up-regulated by TNF and TLR transcriptional signaling. Many types of infection and stress lead to inhibition of inflammatory signaling or general inhibition of protein synthesis. We therefore propose that the absence of FLIP-rather than inhibition of caspase-8-provides a general mechanism for cellular sensitization to necroptosis. We further hypothesize that necroptosis is itself inflammatory, because cells dying by necroptosis release damage- associated signaling molecules that activate immune cells. To address this possibility, we will focus on three specific questions: 1) How is the pro-necroptotic kinase RIPK3 activated, and how is this activation suppressed by caspase-8/FLIP? We have created a system in which multiple steps of RIPK3 can be controlled. We will use this system to test the hypothesis that RIPK3 activation requires phosphorylation- dependent assembly and propagation of a RIPK3 oligomer, and that caspase-8/FLIP directly blocks this process. 2) How is suppression of caspase-8/FLIP relieved to allow necroptosis under physiological conditions? We hypothesize that inhibitors of NF-kB signaling, or of general protein translation, sensitize cells to necroptosis by preventing FLIP expression. We will test this model in multiple cell types using pathologically relevant models of bacterial and viral infection, as well as ER stress. We will also consider how FLIP levels are controlled at both mRNA and protein levels. 3) How does the immune system respond to necroptotic vs. apoptotic cell death? We hypothesize that the mechanism by which a cell dies is important, because necroptosis releases inflammatory molecules that are contained or eliminated during apoptosis. To test this idea, we have created a system that allows us to trigger apoptosis or necroptosis using a non-toxic drug. We will use this system to analyze innate and adaptive immune responses to cell death. Together, the work proposed here seeks to understand the causes and consequences of necroptosis in vivo, and to thereby allow rational design of therapies that manipulate this process in infection, autoimmune disease, and cancer.
描述(由适用提供):肿瘤坏死因子 - (TNF)和Toll样受体(TLR)信号传导通过驱动促炎基因的转录激活,在配位免疫调查中起关键作用。但是,长期以来,人们已经认识到它们也可以引发凋亡细胞死亡。最近,已经表明,这些信号还可以诱导另一种形式的程序性细胞死亡,称为“坏死性”。虽然发现坏死的发现引起了人们的考虑,但这种替代细胞死亡程序的身体作用仍然难以捉摸。特别是,坏死性被凋亡蛋白酶caspase-8阻塞,因此大多数研究依赖于遗传消融或caspase-8的化学抑制来触发坏死。这提出了一个问题:在生理条件下,TNF或TLR介导的坏死症何时发生?我们已经表明,caspase-8必须与其旁系同源物翻转一起起作用以阻断坏死作用,并且FLIP可能会被TNF和TLR转录信号传导上调。许多类型的感染和压力会导致抑制炎症信号传导或对蛋白质合成的一般抑制作用。因此,我们建议缺乏翻转 - 抑制caspase-8提供了一种对坏死性敏感性敏感的一般机制。我们进一步假设坏死作用本身是炎症性的,因为坏死性释放损伤与激活免疫细胞的信号分子死亡的细胞。为了解决这种可能性,我们将重点关注三个特定问题:1)如何激活促氧化激酶RIPK3,以及如何被caspase-8/flip抑制这种激活?我们创建了一个系统,可以控制RIPK3的多个步骤。我们将使用该系统来测试RIPK3激活需要磷酸化依赖性组装和RIPK3低聚物的传播的假设,而caspase-8/Flip直接阻止了此过程。 2)caspase-8/flip的抑制是如何在物理条件下允许坏死的抑制作用?我们假设NF-KB信号传导的抑制剂或通用蛋白质翻译,通过防止翻转表达来对坏死的敏感细胞对坏死。我们将使用细菌和病毒感染的病理相关模型以及ER应力在多种细胞类型中测试该模型。我们还将考虑如何在mRNA和蛋白质水平上控制翻转水平。 3)免疫系统如何应对核凋亡与凋亡细胞死亡?我们假设细胞死亡的机制很重要,因为坏死释放了凋亡过程中包含或消除的炎症分子。为了测试这个想法,我们创建了一个系统,使我们能够使用无毒药物触发凋亡或坏死。我们将使用该系统来分析先天和适应性免疫回避细胞死亡。这里提出的工作共同旨在了解体内坏死性的原因和后果,从而允许合理设计在感染,自身免疫性疾病和癌症中操纵这一过程的疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrew Atwell Oberst其他文献

Andrew Atwell Oberst的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andrew Atwell Oberst', 18)}}的其他基金

"Survivor" neurons drive persistent inflammation following West Nile virus infection
西尼罗河病毒感染后,“幸存者”神经元驱动持续炎症
  • 批准号:
    10731043
  • 财政年份:
    2023
  • 资助金额:
    $ 44.29万
  • 项目类别:
Activation of inflammatory programmed cell death by SARS-CoV-2
SARS-CoV-2 激活炎症性程序性细胞死亡
  • 批准号:
    10615162
  • 财政年份:
    2022
  • 资助金额:
    $ 44.29万
  • 项目类别:
Activation of inflammatory programmed cell death by SARS-CoV-2
SARS-CoV-2 激活炎症性程序性细胞死亡
  • 批准号:
    10450286
  • 财政年份:
    2022
  • 资助金额:
    $ 44.29万
  • 项目类别:
ZBP1 activation
ZBP1激活
  • 批准号:
    10549766
  • 财政年份:
    2021
  • 资助金额:
    $ 44.29万
  • 项目类别:
Training in Cellular & Molecular Biology
蜂窝培训
  • 批准号:
    10427115
  • 财政年份:
    2021
  • 资助金额:
    $ 44.29万
  • 项目类别:
Training in Cellular & Molecular Biology
蜂窝培训
  • 批准号:
    10654830
  • 财政年份:
    2021
  • 资助金额:
    $ 44.29万
  • 项目类别:
ZBP1 activation
ZBP1激活
  • 批准号:
    10208144
  • 财政年份:
    2021
  • 资助金额:
    $ 44.29万
  • 项目类别:
Immune activation by necroptotic cell death
坏死性细胞死亡激活免疫
  • 批准号:
    10318967
  • 财政年份:
    2019
  • 资助金额:
    $ 44.29万
  • 项目类别:
Immune activation by necroptotic cell death
坏死性细胞死亡激活免疫
  • 批准号:
    10544990
  • 财政年份:
    2019
  • 资助金额:
    $ 44.29万
  • 项目类别:
The Role of the RIP Kinases in Coordinating Neuroinflammation and Host Defense
RIP 激酶在协调神经炎症和宿主防御中的作用
  • 批准号:
    10326792
  • 财政年份:
    2018
  • 资助金额:
    $ 44.29万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Defining the role of Wnt11 and Wnt5a in regulating hematopoietic and skeletal stem cell self-renewal potential during homeostasis and stress
定义 Wnt11 和 Wnt5a 在稳态和应激过程中调节造血和骨骼干细胞自我更新潜力的作用
  • 批准号:
    10731650
  • 财政年份:
    2023
  • 资助金额:
    $ 44.29万
  • 项目类别:
Anti-inflammatory signals and neurodegeneration
抗炎信号和神经退行性变
  • 批准号:
    10928425
  • 财政年份:
    2023
  • 资助金额:
    $ 44.29万
  • 项目类别:
Liquid biopsy and radiomics for liver cancer surveillance
用于肝癌监测的液体活检和放射组学
  • 批准号:
    10736720
  • 财政年份:
    2023
  • 资助金额:
    $ 44.29万
  • 项目类别:
Fibroadipogenic progenitor cells as drivers of angiogenesis during muscle regeneration
纤维脂肪祖细胞作为肌肉再生过程中血管生成的驱动因素
  • 批准号:
    10741438
  • 财政年份:
    2023
  • 资助金额:
    $ 44.29万
  • 项目类别:
Pancreatic alpha-cells and Maternal metabolic Adaptation
胰腺α细胞和母体代谢适应
  • 批准号:
    10681909
  • 财政年份:
    2023
  • 资助金额:
    $ 44.29万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了